Jeffrey Allard

946 total citations
14 papers, 759 citations indexed

About

Jeffrey Allard is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeffrey Allard has authored 14 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeffrey Allard's work include HER2/EGFR in Cancer Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jeffrey Allard is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jeffrey Allard collaborates with scholars based in United States, Switzerland and United Kingdom. Jeffrey Allard's co-authors include David Ciarlariello, Jessica Dal Col, Hsiaoyin Mao, Michael A. Caligiuri, Brittany Thomas, Danilo Perrotti, Rossana Trotta, Jianhua Yu, John C. Byrd and Xiaoli Zhang and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Jeffrey Allard

14 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey Allard United States	10	336	206	178	176	168	14	759
John S. Link United States	13	487 1.4×	250 1.2×	141 0.8×	287 1.6×	150 0.9×	23	862
Jennifer A. A. Gubbels United States	10	255 0.8×	353 1.7×	293 1.6×	126 0.7×	105 0.6×	16	786
Jennifer A. Belisle United States	8	234 0.7×	494 2.4×	382 2.1×	129 0.7×	123 0.7×	8	898
Phillip P. Santoiemma United States	7	257 0.8×	209 1.0×	115 0.6×	153 0.9×	50 0.3×	20	613
V. Heilmann Germany	15	342 1.0×	109 0.5×	200 1.1×	67 0.4×	209 1.2×	32	870
Angelika Lahr Germany	9	393 1.2×	260 1.3×	192 1.1×	73 0.4×	271 1.6×	16	757
RE Hawkins United Kingdom	14	192 0.6×	153 0.7×	373 2.1×	72 0.4×	220 1.3×	29	700
Robert A. Somer United States	15	946 2.8×	255 1.2×	215 1.2×	417 2.4×	115 0.7×	34	1.3k
V. Fermeaux France	10	400 1.2×	158 0.8×	208 1.2×	58 0.3×	255 1.5×	30	847
Hester van Cruijsen Netherlands	16	389 1.2×	224 1.1×	351 2.0×	227 1.3×	92 0.5×	23	962

Countries citing papers authored by Jeffrey Allard

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Allard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Allard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Allard more than expected).

Fields of papers citing papers by Jeffrey Allard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Allard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Allard. The network helps show where Jeffrey Allard may publish in the future.

Co-authorship network of co-authors of Jeffrey Allard

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Allard. A scholar is included among the top collaborators of Jeffrey Allard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Allard. Jeffrey Allard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Shin, Dongwon, Jonathan D. Poplawsky, Matthew F. Chisholm, et al.. (2024). The many faces of θ'-Al2Cu precipitates: Energetics of pristine and solute segregated Al/θ' semi-coherent interfaces. Acta Materialia. 281. 120444–120444. 6 indexed citations

Trotta, Rossana, Jessica Dal Col, Jianhua Yu, et al.. (2008). TGF-β Utilizes SMAD3 to Inhibit CD16-Mediated IFN-γ Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells. The Journal of Immunology. 181(6). 3784–3792. 207 indexed citations

Allard, Jeffrey, et al.. (2008). Use of a novel biomarker HE4 for monitoring patients with epithelial ovarian cancer. Journal of Clinical Oncology. 26(15_suppl). 5535–5535. 12 indexed citations

Brown, Aaron C., Caitlyn Miller, Katina Robison, et al.. (2008). Differential expression of CA125 and a novel serum tumor marker HE4 in epithelial ovarian cancer. Journal of Clinical Oncology. 26(15_suppl). 5533–5533. 6 indexed citations

Trotta, Rossana, David Ciarlariello, Jessica Dal Col, et al.. (2007). The PP2A inhibitor SET regulates natural killer cell IFN-γ production. The Journal of Experimental Medicine. 204(10). 2397–2405. 43 indexed citations

Pass, Harvey I., Anil Wali, Naimei Tang, et al.. (2007). Soluble Mesothelin-Related Peptide Level Elevation in Mesothelioma Serum and Pleural Effusions. The Annals of Thoracic Surgery. 85(1). 265–272. 113 indexed citations

Badgwell, Donna, Zhen Lü, Laurence A. Cole, et al.. (2007). Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment. Gynecologic Oncology. 106(3). 490–497. 55 indexed citations

Clark, Roger, et al.. (2004). How Much of the Sky? Women in American High School History Textbooks from the 1960s, 1980s and 1990s. Social Education. 68(1). 57. 38 indexed citations

Ali, Suhail M., Kim Leitzel, Vernon M. Chinchilli, et al.. (2002). Relationship of Serum HER-2/neu and Serum CA 15-3 in Patients with Metastatic Breast Cancer. Clinical Chemistry. 48(8). 1314–1320. 61 indexed citations

10.

Lipton, Allan, Suhail M. Ali, Kim Leitzel, et al.. (2002). Elevated Serum HER-2/neu Level Predicts Decreased Response to Hormone Therapy in Metastatic Breast Cancer. Journal of Clinical Oncology. 20(6). 1467–1472. 107 indexed citations

11.

Allard, Jeffrey, Gareth Davies, Anne Dawnay, et al.. (2001). Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 38(3). 188–216. 33 indexed citations

12.

Payne, Robert C., et al.. (2000). Automated Assay for HER-2/neu in Serum. Clinical Chemistry. 46(2). 175–182. 74 indexed citations

13.

Allard, Jeffrey, et al.. (1999). 1040 Treatment results for patients treated with cobalt and 6 MV in head and neck cancers. International Journal of Radiation Oncology*Biology*Physics. 45(3). 277–277. 1 indexed citations

14.

Brawer, Michael K., Daniel D. Bankson, Alan W. Partin, et al.. (1999). COMPLEXED PROSTATE SPECIFIC ANTIGEN (cPSA). The Journal of Urology. 208–208. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact